Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: International Multi-center Double-blind Comparative Randomized Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 (JSC "BIOCAD", Russia) 120 mcg or 180 mcg Intramuscularly,
Brief Summary: International multi-center double-blind comparative randomized clinical trial to evaluate efficacy, safety and tolerance of BCD-054 (JSC "BIOCAD", Russia) 120 mcg or 180 mcg intramuscularly, biweekly and Avonex® (Biogen Idec Limited, Great Britain) 30 mcg, weekly, for treatment of patients with remitting multiple sclerosis